Kamille Fogh

Copenhagen, 2100, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.

The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.

Journal: Viruses

Published: May 02, 2024

Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes.

Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes.

Journal: AIDS (London, England)

Published: March 20, 2024

Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection.

Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection.

Journal: The Journal of infectious diseases

Published: January 05, 2024

Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.

Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.

Journal: Viruses

Published: October 28, 2023

Surveillance of SARS-CoV-2 infection based on self-administered swabs, Denmark, May to July 2022: evaluation of a pilot study.

Surveillance of SARS-CoV-2 infection based on self-administered swabs, Denmark, May to July 2022: evaluation of a pilot study.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: September 21, 2023

Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workers.

Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workers.

Journal: PloS one

Published: August 25, 2023

Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis.

Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis.

Journal: Journal of neuroimmunology

Published: August 22, 2023

SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments.

SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments.

Journal: Journal of internal medicine

Published: April 06, 2023

Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination.

Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination.

Journal: Microbiology spectrum

Published: March 06, 2023

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.

Journal: EBioMedicine

Published: February 28, 2023

Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies.

Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies.

Journal: European journal of haematology

Published: February 22, 2023

Reply to Brandt et al., "Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID".

Reply to Brandt et al., "Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID".

Journal: Microbiology spectrum

Published: February 14, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026